Name: Protocol for Single-Cell Dissociation, RNA Sequencing, and Isolation of Myoepithelial Cells and Fibroblasts from the Aged Lacrimal and Salivary Glands (Video) | JoVE Journal
Uploaded: 2026-04-24T13:25:00.000+00:00
Duration: 8 min 37 s
Description: Learn single-cell dissociation and RNA sequencing for aged lacrimal glands using optimized enzymatic digestion and FACS. This protocol enables high-quality isolation of myoepithelial cells and fibroblasts.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work has been supported by the National Institute of Health, the National Eye Institute (NEI), USA, grants 5R01EY026202, R01EY035333; the National Institute of Dental and Craniofacial Research (NIDCR) grants R01DE031044, 2R01DE014756, and National Cancer Institute (NCI) grant 5R01CA271500.

All animal experiments were conducted in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) at The Scripps Research Institute (protocol no. 08-0123; approved on August 29, 2023). The animal care at The Scripps Research Institute is accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care, International (AAALAC). Mice were maintained under a standard 12 h light/12 h dark cycle with food and water provided ad libitum. PdgfraEGFP and Acta2GFP transgenic mouse lines were used for experiments. The detailed information on mouse lines is provided in the &#34;Table of materials&#34; section.
1. General considerations
<ol>
	<li>Follow NIH Universal Precautions17 when handling biohazardous materials and animal tissues. Perform all animal work in accordance with approved IACUC protocols and designated Animal Biosafety Levels.</li>
	<li>Follow standard laboratory safety practices by avoiding mouth pipetting, minimizing sharps use, using a biological safety cabinet for aerosol-generating procedures, wearing appropriate PPE, disposing of sharps in puncture-resistant containers, and properly labeling and decontaminating all biohazardous waste prior to disposal.</li>
	<li>Routinely decontaminate work surfaces and equipment using appropriate disinfectants (e.g., 10% bleach).</li>
	<li>Perform all centrifugation steps at 4 &#176;C in a pre-cooled refrigerated centrifuge to preserve cell viability and minimize temperature-induced stress.</li>
	<li>Optimize flow cytometer and cell sorter settings for the specific instrument configuration and adjust parameters for each antibody-fluorophore conjugate using appropriate control samples. Use the same cytometer and sorting instrument, with fixed, optimized settings, throughout an experimental series to minimize variability.</li>
	<li>Prepare selected solutions up to one day in advance and store appropriately until use. Prepare all solutions under sterile conditions in a biosafety cabinet.</li>
	<li>Keep Ca2+/Mg2+-containing solutions separate from EDTA-containing buffers to prevent chelation during enzymatic steps. All reagents needed for this procedure are shown in Table of Materials.</li>
</ol>
2. Plasticware
<ol>
	<li>In sterile conditions, pre-coat dishes, tubes, and syringes with 1x PBS + 1% BSA for 1 h at room temperature (RT). Aspirate and keep everything sterile until use.</li>
	<li>Pre-coat pipette tips. Aspirate and dispense 1x PBS + 1% BSA three times with each tip to coat the inner surface. Place the coated tips back into the sterile tip box and allow them to dry overnight in a sterile incubator. Use these pre-coated tips the next day during the cell isolation procedure.</li>
</ol>
3. Solutions and buffers
<ol>
	<li>DNase I Stock (5 mg/mL)
	<ol>
		<li>Prepare 150 mM NaCl from the 5M NaCl stock and sterile-filter the solution.</li>
		<li>Add 1 M CaCl&#8322; to the filtered 150 mM NaCl solution to obtain a final concentration of 5 mM CaCl&#8322;.</li>
		<li>Resuspend 100 mg DNase I in 20 ml of 150 mM NaCl / 5 mM CaCl&#8322; buffer to obtain a 5 mg/mL DNase I stock solution.</li>
		<li>Prepare 500 &#181;L aliquots and store them at &#8722;20 &#176;C for up to 6 months. Avoid repeated freeze-thaw cycles to prevent loss of enzyme activity.</li>
	</ol>
	</li>
	<li>Digestion medium
	<ol>
		<li>The day before the experiment, prepare the medium base mix by mixing DMEM/F12 with 0.5% BSA and filter it.</li>
		<li>Add 1M HEPES and 1M CaCl&#8322; to the base medium DMEM/F12 / 0.5% BSA to obtain final concentrations of 15 mM and 3 mM, respectively.</li>
		<li>Add all following enzymes right before use: Collagenase IV (1 mg/mL; 125 U/mL), Dispase II (2.5 mg/mL; 1.25 U/mL), and DNase I (20 U/mL; 0.05 mg/mL from the 5 mg/mL stock).</li>
	</ol>
	</li>
	<li>Blocking Medium 1 (BM1)
	<ol>
		<li>Add 1M HEPES and 0.5M EDTA to 1x HBSS to obtain final concentrations of 15 mM and 3 mM, respectively.</li>
	</ol>
	</li>
	<li>Blocking Medium 2 (BM2)
	<ol>
		<li>Add FBS and 1M HEPES to DMEM/F12 to obtain final concentrations of 10% and 15 mM, respectively.</li>
	</ol>
	</li>
	<li>Medium for DNase treatment
	<ol>
		<li>The day before the experiment, prepare the base medium by mixing 1x HBSS with 0.5% BSA and filter it.</li>
		<li>Add 1M HEPES, 1M CaCl&#8322;, and 1M MgCl&#8322; to the base medium 1x HBSS / 0.5% BSA to obtain final concentrations of 10 mM, 1.5 mM, and 2 mM, respectively.</li>
		<li>Right before use, add DNase I (200 U/mL; 0.5 mg/mL from the 5 mg/mL stock) into the prepared mix.</li>
	</ol>
	</li>
	<li>Blocking Medium 3 (BM3)
	<ol>
		<li>Use the same filtered base medium 1x HBSS / 0.5% BSA and add 1M HEPES and 0.5M EDTA to obtain final concentrations of 10 mM and 1 mM, respectively.</li>
	</ol>
	</li>
	<li>Blocking Medium 4 (BM4)
	<ol>
		<li>Use the same filtered base medium 1x HBSS / 0.5% BSA and add 1M HEPES to obtain final concentrations of 10 mM.</li>
	</ol>
	</li>
	<li>FACS Buffer
	<ol>
		<li>The day before the experiment, prepare the base medium by mixing 1x DPBS with 0.5% BSA and filter it.</li>
		<li>Add 1M HEPES and 0.5M EDTA to 1x DPBS / 0.5% BSA to obtain final concentrations of 25 mM and 1 mM, respectively.</li>
	</ol>
	</li>
	<li>Medium for scRNAseq (MSC)
	<ol>
		<li>The day before the experiment, prepare the medium by mixing 1x DPBS with 0.4% BSA and filter it.</li>
	</ol>
	</li>
</ol>
4. Tissue harvesting and microdissection (~ 40 - 50 min)
<ol>
	<li>Anesthetize the mouse with isoflurane and euthanize by cervical dislocation in accordance with institutional IACUC guidelines.</li>
	<li>Use fine forceps and scissors to incise the skin between the eye and the ear and gently retract it to expose the lacrimal gland.</li>
	<li>To isolate the gland, lift it slightly using a dull-tipped forceps and carefully separate the surrounding connective tissue by gently teasing it away in a circular motion. The boundaries of the lacrimal gland are clearly visible, allowing easy separation from adjacent tissues, including the parotid gland.</li>
	<li>Transfer the lacrimal gland (each gland weighing approximately 10-25 mg, depending on mouse weight, sex, and age) to a 35 mm Petri dish containing 2 mL of cold 1x PBS on ice. Under a dissecting microscope, remove the remaining fat and carefully peel off the connective tissue capsule using two forceps.</li>
	<li>Confirm cell labeling by examining a small tissue fragment under a fluorescence microscope and verifying the expected reporter or fluorescent signal before proceeding to enzymatic digestion.</li>
	<li>Place a sterile 35 mm Petri dish on ice and add 800-1000 &#181;L of cold 1x PBS (volume adjusted to gland size) to the center of the dish. Transfer one lacrimal gland into the 1x PBS.</li>
	<li>Using two sterile scalpels, finely mince the gland into small fragments until it reaches a soft, paste-like consistency. Ensure that the tissue fragments remain submerged in PBS throughout the mincing process, but do not allow them to float freely across the dish.</li>
	<li>Collect tissue fragments at one side of the dish, aspirate residual PBS, and wash fragments with 1 mL of fresh cold PBS.</li>
	<li>Transfer washed tissue fragments into a 6-well plate containing 2 mL per well of pre-warmed digestion medium. Keep the plate on ice until all samples are processed.</li>
</ol>
5. First enzymatic digestion (~1.5 - 2 h)
<ol>
	<li>Incubate the plate in a shaking water bath at 37 &#176;C, 60 rpm for 30 min.</li>
	<li>Gently triturate the tissue 15 times using a wide-bore 1 mL tip, then return the plate to the shaking water bath at 37 &#176;C, 60 rpm for an additional 30 min.</li>
	<li>Gently triturate the sample 10 times using a regular 1 mL tip, then return the plate to the shaking water bath at 37 &#176;C, 60 rpm for an additional 30 min.</li>
	<li>Gently triturate the sample 10 times and transfer the cell suspension into 2 mL Dolphin microcentrifuge tubes.</li>
	<li>Add 1 mL of cold BM1 to each well of the plate to collect the remaining digestion medium containing residual cells. Place the plate on ice until the next step. 
	NOTE: If large cell clusters or tissue fragments are still observed at this stage, extend each incubation step by an additional 10-20 min. Do not exceed the indicated number of trituration passes (maximum 10-15 gentle passes), as additional mechanical stress will compromise cell viability.</li>
</ol>
6. Termination of enzymatic activity and primary washes (~ 15 min)
<ol>
	<li>Centrifuge the tubes containing the cell suspension at 300 &#215; g for 5 min at 4 &#176;C.</li>
	<li>Discard the supernatant. Transfer the BM1 from each well of the initial plate (containing residual cells) into the corresponding tube and gently resuspend the cell pellets.</li>
	<li>Rinse each well with an additional 600 &#181;L of cold BM1 and combine the wash with the corresponding tube to collect all remaining cells.</li>
	<li>Gently resuspend the cell suspension, centrifuge again at 300 &#215; g for 5 min at 4 &#176;C, and discard the supernatant.</li>
</ol>
7. Accutase and DNase treatment (~ 30 - 35 min)
<ol>
	<li>Add 1 mL of Accutase to the cell pellets and gently resuspend. Incubate the tube for only 5-10 min at 37 &#176;C and 60 rpm. 
	NOTE: Place the tube on its side during incubation to prevent cells from settling and sticking to the bottom.</li>
	<li>Gently triturate 10 times using a 1 mL pipette tip.</li>
	<li>Add 1 mL of cold BM2 to terminate the enzymatic reaction by diluting the Accutase.</li>
	<li>Centrifuge at 300 &#215; g for 5 min at 4 &#176;C and discard the supernatant.</li>
	<li>Resuspend the cells in the medium for DNase treatment, filling the tube up to the top.</li>
	<li>Incubate for 10 min at RT, gently resuspending once after 5 min.</li>
	<li>Meanwhile, pre-wet a 70 &#181;m cell strainer with 1 mL of BM3 placed over a 15 mL conical tube.</li>
	<li>Transfer the cell suspension onto the strainer.</li>
	<li>Rinse the original collection tube with 1 mL of BM3 and transfer the rinse onto the same strainer.</li>
	<li>Wash the strainer with an additional 5 mL of BM3.</li>
</ol>
8. Cell counting and viability check
<ol>
	<li>Take 10 &#181;L of the filtered cell suspension in BM3 and mix with 10 &#181;L of Trypan Blue. Determine cell concentration and viability using Trypan Blue exclusion and quantify by manual counting or an automated cell counter (e.g., Countess 3 Automated Cell Counter). Proceed further only if viability meets the required threshold for downstream applications (typically &#8805;70-80%). 
	NOTE: Consider the total volume ~7-9 mL now in the 15 mL tube when calculating yield.</li>
	<li>Proceed according to the downstream application. For scRNA-seq, continue to Section 9. For flow cytometry-based cell sorting, continue to Section 10. 
	NOTE: The scRNA-seq workflow includes RBC lysis and magnetic dead-cell removal to reduce debris and ambient RNA and improve data quality. However, these steps may bias cell-type representation by preferentially affecting fragile or rare epithelial populations, including acinar cells. For flow cytometry-based sorting, these steps were omitted to maximize recovery and preserve cell-surface epitopes. Workflow selection should therefore be guided by experimental goals, prioritizing data quality for scRNA-seq or cell recovery and viability for sorting and downstream applications.</li>
</ol>
9. Preparation of cells for scRNA-seq (~ 1 - 1.5 h)
<ol>
	<li>Prepare 1x RBC solution by reconstituting 10x solution with milliQ water.</li>
	<li>Centrifuge the 15 mL tube containing the cell suspension at 400 &#215; g for 5 min at 4 &#176;C and discard the supernatant.</li>
	<li>Resuspend the cell pellet in 5 mL 1x RBC buffer and incubate for 5 min at RT.</li>
	<li>Centrifuge again at 300 &#215; g for 5 min at 4 &#176;C and discard the supernatant.</li>
	<li>Resuspend the cell pellet in 2 mL cold BM4.</li>
	<li>Take 10 &#181;L of the filtered cell suspension in BM4 and mix with 10 &#181;L of Trypan Blue to assess cell concentration and viability.</li>
	<li>Pre-wet the MACS 30 &#181;m strainer with 1 mL 1x HBSS and filter the cell suspension through the strainer into a 15 mL tube.</li>
	<li>Rinse the previous collection tube with 2 mL of cold BM4 and pass the wash through the same strainer into the 15 mL tube.</li>
	<li>Wash the strainer with an additional 10 mL cold BM4.</li>
	<li>Centrifuge the 15 mL tube at 400 &#215; g for 5 min at 4 &#176;C and completely remove the supernatant.</li>
	<li>Gently resuspend the pellet in 100 &#181;L of MACS Microbeads and incubate for 15 min at RT.</li>
	<li>Meanwhile, prepare 1x Binding Buffer (BB) from Dead Cell Removal Kit using sterile double-distilled water.</li>
	<li>Wash a MACS MS column with 500 &#181;L 1x BB to equilibrate.</li>
	<li>Add 400 &#181;L BB to the sample, resuspend the cells with Microbeads and apply the entire volume onto the equilibrated MS column. Collect the flow-through into a 15 mL tube.</li>
	<li>Wash the column four times with 500 &#181;L BB each, collecting all flow-through fractions.</li>
	<li>Centrifuge the collected flow-through at 400 &#215; g for 5 min at 4 &#176;C and discard the supernatant.</li>
	<li>Resuspend the cells in 400 &#181;L of MSC buffer and transfer the suspension to a 1.5 mL tube.</li>
	<li>Rinse the previous tube with 700 &#181;L MSC buffer and pool the rinse with the sample.</li>
	<li>Centrifuge at 400 &#215; g for 5 min at 4 &#176;C and discard the supernatant.</li>
	<li>Resuspend the cell pellet in MSC buffer using a wide-bore tip up to a final volume of around 1.5 mL.</li>
	<li>Centrifuge again at 400 &#215; g for 5 min at 4 &#176;C and discard the supernatant.</li>
	<li>Leave ~100 &#181;L of supernatant, gently resuspend the pellet, and count the cells again by mixing 6 &#181;L cells with 6 &#181;L Trypan Blue.</li>
	<li>Adjust the final volume with MSC buffer to achieve 700-1200 cells/&#181;L and recount cells to confirm cell concentration.</li>
	<li>Ensure cell viability after RBC lysis and dead-cell removal is &#8805; 70% (typically 70-95%) prior to loading for 10x Chromium processing (Chromium Single Cell 3&#39; Solution V3).</li>
	<li>Apply basic scRNA-seq quality control criteria: nUMI &#62; 500, nGene &#62; 200, and mitochondrial gene fraction &#60;15%. Use a permissive mitochondrial threshold (15%) to preserve epithelial populations with higher metabolic activity. Include only cells meeting all QC criteria in downstream analyses. 
	NOTE: These QC thresholds represent example values derived from our datasets (Supplementary Figure 1) and were reported in our previous publication18.</li>
</ol>
10. Preparation of cells for flow cytometry-based cell sorting (~ 1 - 1.5 h)
<ol>
	<li>For flow cytometry-based isolation of MECs and fibroblasts, PdgfraEGFP and Acta2GFP reporter mouse lines were used, respectively, to enable precise identification of each population.</li>
	<li>Centrifuge the 15 mL tube with cell suspension at 400 &#215; g for 5 min at 4 &#176;C and discard supernatant.</li>
	<li>Resuspend the cell pellet in cold FACS buffer to a final concentration of 5 x 10&#8309; to 2 x 106 cells per 100 &#181;L.</li>
	<li>Prepare the controls required for FACS compensation: negative control - unstained cells from a wild-type mouse, background fluorescence control - unstained cells from Acta2GFP and PdgfraEGFP mice, single-stain control - cells from a wild-type mouse stained individually with each antibody used in the experiment. 
	NOTE: For each control sample, use at least 1 &#215; 10&#8309; cells resuspended in 100 &#181;L of FACS buffer.</li>
	<li>Add FcBlock (1:100) and incubate for 5 min on ice.</li>
	<li>Add CD326 (EpCAM)-APC monoclonal antibody (1:100) or CD140a (PDGFR&#945;) monoclonal antibody (1:100). Incubate for 45 min on ice, protected from light.</li>
	<li>Gently resuspend the cells every 15 min during antibody incubation.</li>
	<li>Fill each tube to the top with cold FACS buffer and centrifuge at 300 &#215; g for 5 min at 4 &#176;C.</li>
	<li>Prepare FxCycle working solution (1:1000) in FACS buffer.</li>
	<li>Resuspend samples in 1 mL and controls in 500 &#181;L of cold FACS buffer with FxCycle.</li>
	<li>Transfer all samples to FACS tubes and keep them on ice, protected from light.</li>
	<li>Proceed immediately to the Flow Cytometry Core for sorting. Collect sorted cells into FACS buffer, culture medium, lysis buffer, or RNAlater, depending on downstream applications. 
	NOTE: Instrument settings (e.g., nozzle size and pressure) and event rates depend on the sorter configuration and target cell population; therefore, a preliminary pilot run is recommended to determine optimal parameters for each experiment.</li>
</ol>

<ol><li>Guo, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Aging+and+aging-related+diseases%3A+from+molecular+mechanisms+to+interventions+and+treatments%5BTitle%5D)+AND+%22Signal+Transduct+Target+Ther%22%5BJournal%5D)">Aging and aging-related diseases: from molecular mechanisms to interventions and treatments.</a> Signal Transduct Target Ther. 7 (1), 391(2022).</li>
<li>Zhang, X., Wang, L., Zheng, Y., Deng, L., Huang, X. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Prevalence+of+dry+eye+disease+in+the+elderly%3A+A+protocol+of+systematic+review+and+meta-analysis%5BTitle%5D)+AND+%22Medicine+%28Baltimore%29%22%5BJournal%5D)">Prevalence of dry eye disease in the elderly: A protocol of systematic review and meta-analysis.</a> Medicine (Baltimore). 99 (37), e22234(2020).</li>
<li>Donthineni, P. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Aqueous-deficient+dry+eye+disease%3A+Preferred+practice+pattern+guidelines+on+clinical+approach%2C+diagnosis%2C+and+management%5BTitle%5D)+AND+%22Indian+J+Ophthalmol%22%5BJournal%5D)">Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management.</a> Indian J Ophthalmol. 71 (4), 1332-1347 (2023).</li>
<li>Yuksel, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Aging+Affects+Lipid+Homeostasis+in+Lacrimal+Glands+by+Upregulating+Lipogenesis+and+Changing+Its+Specificity%5BTitle%5D)+AND+%22Invest+Ophthalmol+Vis+Sci%22%5BJournal%5D)">Aging Affects Lipid Homeostasis in Lacrimal Glands by Upregulating Lipogenesis and Changing Its Specificity.</a> Invest Ophthalmol Vis Sci. 66 (13), 1(2025).</li>
<li>Galletti, J. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ectopic+lymphoid+structures+in+the+aged+lacrimal+glands%5BTitle%5D)+AND+%22Clin+Immunol%22%5BJournal%5D)">Ectopic lymphoid structures in the aged lacrimal glands.</a> Clin Immunol. 248, 109251(2023).</li>
<li>Delcroix, V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Lacrimal+Gland+Epithelial+Cells+Shape+Immune+Responses+through+the+Modulation+of+Inflammasomes+and+Lipid+Metabolism%5BTitle%5D)+AND+%22Int+J+Mol+Sci%22%5BJournal%5D)">Lacrimal Gland Epithelial Cells Shape Immune Responses through the Modulation of Inflammasomes and Lipid Metabolism.</a> Int J Mol Sci. 24 (5), 4309(2023).</li>
<li>Mauduit, O., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Spatial+transcriptomics+of+the+lacrimal+gland+features+macrophage+activity+and+epithelium+metabolism+as+key+alterations+during+chronic+inflammation%5BTitle%5D)+AND+%22Front+Immunol%22%5BJournal%5D)">Spatial transcriptomics of the lacrimal gland features macrophage activity and epithelium metabolism as key alterations during chronic inflammation.</a> Front Immunol. 13, 1011125(2022).</li>
<li>Prasad, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Assessing+the+Independent+and+Combined+Effects+of+Hyperosmolarity+and+Inflammatory+Stress+on+Human+Corneal+Epithelial+Cells%5BTitle%5D)+AND+%22Invest+Ophthalmol+Vis+Sci%22%5BJournal%5D)">Assessing the Independent and Combined Effects of Hyperosmolarity and Inflammatory Stress on Human Corneal Epithelial Cells.</a> Invest Ophthalmol Vis Sci. 66 (13), 47(2025).</li>
<li>Scholand, K. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Heterochronic+Parabiosis+Causes+Dacryoadenitis+in+Young+Lacrimal+Glands%5BTitle%5D)+AND+%22Int+J+Mol+Sci%22%5BJournal%5D)">Heterochronic Parabiosis Causes Dacryoadenitis in Young Lacrimal Glands.</a> Int J Mol Sci. 24 (5), 4897(2023).</li>
<li>Molla Desta, G., Birhanu, A. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Advancements+in+single-cell+RNA+sequencing+and+spatial+transcriptomics%3A+transforming+biomedical+research%5BTitle%5D)+AND+%22Acta+Biochim+Pol%22%5BJournal%5D)">Advancements in single-cell RNA sequencing and spatial transcriptomics: transforming biomedical research.</a> Acta Biochim Pol. 72, 13922(2025).</li>
<li>Jungblut, M., Oeltze, K., Zehnter, I., Hasselmann, D., Bosio, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Standardized+preparation+of+single-cell+suspensions+from+mouse+lung+tissue+using+the+gentleMACS+Dissociator%5BTitle%5D)+AND+%22J+Vis+Exp%22%5BJournal%5D)">Standardized preparation of single-cell suspensions from mouse lung tissue using the gentleMACS Dissociator.</a> J Vis Exp. (29), e1266(2009).</li>
<li>Jankelow, A., Almeida-Porada, G., Atala, A., Sawyer, S. W., Porada, C. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Recent+advancements+in+tissue+dissociation+techniques+for+cell+manufacturing+single-cell+analysis+and+downstream+processing%5BTitle%5D)+AND+%22Stem+Cells+Transl+Med%22%5BJournal%5D)">Recent advancements in tissue dissociation techniques for cell manufacturing single-cell analysis and downstream processing.</a> Stem Cells Transl Med. 14 (11), szaf055(2025).</li>
<li>Duong, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+Rapid+Human+Lung+Tissue+Dissociation+Protocol+Maximizing+Cell+Yield+and+Minimizing+Cellular+Stress%5BTitle%5D)+AND+%22Am+J+Respir+Cell+Mol+Biol%22%5BJournal%5D)">A Rapid Human Lung Tissue Dissociation Protocol Maximizing Cell Yield and Minimizing Cellular Stress.</a> Am J Respir Cell Mol Biol. 71 (5), 509-518 (2024).</li>
<li>Koenitzer, J. R., Wu, H., Atkinson, J. J., Brody, S. L., Humphreys, B. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Single-Nucleus+RNA-Sequencing+Profiling+of+Mouse+Lung%3A+Reduced+Dissociation+Bias+and+Improved+Rare+Cell-Type+Detection+Compared+with+Single-Cell+RNA+Sequencing%5BTitle%5D)+AND+%22Am+J+Respir+Cell+Mol+Biol%22%5BJournal%5D)">Single-Nucleus RNA-Sequencing Profiling of Mouse Lung: Reduced Dissociation Bias and Improved Rare Cell-Type Detection Compared with Single-Cell RNA Sequencing.</a> Am J Respir Cell Mol Biol. 63 (6), 739-747 (2020).</li>
<li>Ikeuchi, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Dissociation+of+murine+oral+mucosal+tissues+for+single+cell+applications%5BTitle%5D)+AND+%22J+Immunol+Methods%22%5BJournal%5D)">Dissociation of murine oral mucosal tissues for single cell applications.</a> J Immunol Methods. 525, 113605(2024).</li>
<li>Denisenko, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Systematic+assessment+of+tissue+dissociation+and+storage+biases+in+single-cell+and+single-nucleus+RNA-seq+workflows%5BTitle%5D)+AND+%22Genome+Biol%22%5BJournal%5D)">Systematic assessment of tissue dissociation and storage biases in single-cell and single-nucleus RNA-seq workflows.</a> Genome Biol. 21 (1), 130(2020).</li>
<li>Kahwaji, N. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aKahwaji%2C+N+%22Universal+Precautions%22">Universal Precautions</a>. , StatPearls Publishing. Treasure Island, FL. (2024).</li>
<li>Delcroix, V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+First+Transcriptomic+Atlas+of+the+Adult+Lacrimal+Gland+Reveals+Epithelial+Complexity+and+Identifies+Novel+Progenitor+Cells+in+Mice%5BTitle%5D)+AND+%22Cells%22%5BJournal%5D)">The First Transcriptomic Atlas of the Adult Lacrimal Gland Reveals Epithelial Complexity and Identifies Novel Progenitor Cells in Mice.</a> Cells. 12 (10), 1435(2023).</li>
<li>Mauduit, O., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+closer+look+into+the+cellular+and+molecular+biology+of+myoepithelial+cells+across+various+exocrine+glands%5BTitle%5D)+AND+%22Ocul+Surf%22%5BJournal%5D)">A closer look into the cellular and molecular biology of myoepithelial cells across various exocrine glands.</a> Ocul Surf. 31, 63-80 (2024).</li>
<li>Zyrianova, T., Basova, L. V., Makarenkova, H. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Isolation+of+Myoepithelial+Cells+from+Adult+Murine+Lacrimal+and+Submandibular+Glands%5BTitle%5D)+AND+%22J+Vis+Exp%22%5BJournal%5D)">Isolation of Myoepithelial Cells from Adult Murine Lacrimal and Submandibular Glands.</a> J Vis Exp. (148), e59602(2019).</li>
<li>Montanari, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Automated-Mechanical+Procedure+Compared+to+Gentle+Enzymatic+Tissue+Dissociation+in+Cell+Function+Studies%5BTitle%5D)+AND+%22Biomolecules%22%5BJournal%5D)">Automated-Mechanical Procedure Compared to Gentle Enzymatic Tissue Dissociation in Cell Function Studies.</a> Biomolecules. 12 (5), 701(2022).</li>
<li>Liang, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Dissociation+of+skeletal+muscle+for+flow+cytometric+characterization+of+immune+cells+in+macaques%5BTitle%5D)+AND+%22J+Immunol+Methods%22%5BJournal%5D)">Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques.</a> J Immunol Methods. 425, 69-78 (2015).</li>
<li>Adam, M., Potter, A. S., Potter, S. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Psychrophilic+proteases+dramatically+reduce+single-cell+RNA-seq+artifacts%3A+a+molecular+atlas+of+kidney+development%5BTitle%5D)+AND+%22Development%22%5BJournal%5D)">Psychrophilic proteases dramatically reduce single-cell RNA-seq artifacts: a molecular atlas of kidney development.</a> Development. 144 (19), 3625-3632 (2017).</li>
<li>Reichard, A., Asosingh, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Best+Practices+for+Preparing+a+Single+Cell+Suspension+from+Solid+Tissues+for+Flow+Cytometry%5BTitle%5D)+AND+%22Cytometry+A%22%5BJournal%5D)">Best Practices for Preparing a Single Cell Suspension from Solid Tissues for Flow Cytometry.</a> Cytometry A. 95 (2), 219-226 (2019).</li>
<li>Volovitz, I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+non-aggressive%2C+highly+efficient%2C+enzymatic+method+for+dissociation+of+human+brain-tumors+and+brain-tissues+to+viable+single-cells%5BTitle%5D)+AND+%22BMC+Neurosci%22%5BJournal%5D)">A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells.</a> BMC Neurosci. 17 (1), 30(2016).</li>
<li>Lai, T. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Different+methods+of+detaching+adherent+cells+and+their+effects+on+the+cell+surface+expression+of+Fas+receptor+and+Fas+ligand%5BTitle%5D)+AND+%22Sci+Rep%22%5BJournal%5D)">Different methods of detaching adherent cells and their effects on the cell surface expression of Fas receptor and Fas ligand.</a> Sci Rep. 12 (1), 5713(2022).</li>
</ol>

All authors declare that they have no conflicts of interest.

Here, we optimized and evaluated a significantly improved protocol for generating single-cell suspensions from exocrine tissues, focusing on the lacrimal gland. Using this approach, we generated clean, high-quality single-cell suspensions from both old and young LGs, suitable for single-cell sequencing and other downstream applications. 
Despite the availability of numerous tissue dissociation protocols, it was necessary for us to modify and optimize them to efficiently recover those cell popu...

The lacrimal gland (LG) is an exocrine tubuloacinar gland responsible for secreting the aqueous layer of the tear film. Throughout life, the corneal surface and the LG are exposed to bacterial and viral infections, which may lead to systemic disruption of epithelial cells, induction of chronic inflammatory responses, immune cell infiltration into the LG, and a lack of regeneration. Aging is accompanied by an increased incidence of chronic inflammatory diseases1. Among these, dry eye disease (DED) is one of the ten most common causes of visual impairment worldwide and is a major contributor to decreased independence, mobility, and daily functioning in the elderly population2. A primary cause of DED is LG dysfunction3.
With advancing age, the mouse and human LG undergo pronounced structural and functional alterations, including acinar cell atrophy, ductal dilation, immune cell infiltration, fibrosis, and lipid deposition4,5,6,7. These degenerative changes are also accompanied by chronic inflammation of the LG and tissue fibrosis3,5,8,9. Despite the clear association between aging and LG pathology, the molecular and cellular mechanisms driving these changes remain poorly understood.
Single-cell RNA sequencing enables comprehensive profiling of cell populations and their transcriptional changes during aging10. This approach allows unbiased identification of distinct cell types and states within the lacrimal gland, revealing how aging alters gene expression profiles, immune cell infiltration, and epithelial-mesenchymal interactions.
At present, numerous tissue dissociation methods are available, including mechanical dissociation methods11 and protocols involving warm enzymatic digestion at 37 &#176;C with enzymes such as Collagenase, Dispase, or Trypsin12. Various dissociation strategies have been described for a wide range of tissues, including liver, lung, kidney, heart, and multiple tumor types13,14,15. However, preparing viable single-cell suspensions from aged lacrimal gland tissue remains technically challenging because of increased fibrosis and cellular fragility. Also, as we have reported previously, recovery of fragile acinar cells can be challenging, as dissociation-associated changes in membrane permeability may increase ambient RNA release from these large, secretory cells, contributing to background signal in downstream single-cell datasets16. Although several studies have reported scRNA-seq atlases of aging lacrimal glands, the quality of these datasets has been limited by suboptimal dissociation methods, resulting in a lower yield of epithelial cells than of stromal populations. Here, we present a detailed, optimized protocol for the efficient dissociation of aged mouse LG and the isolation of distinct cell populations for downstream scRNA-seq and bulk RNA-seq analyses (Figure 1). This approach provides a powerful tool to study the molecular mechanisms underlying age-related lacrimal gland dysfunction.
The protocol enables the generation of high-quality, viable single-cell suspensions from aged lacrimal glands, providing a reliable foundation for comprehensive transcriptomic analyses. It allows detailed identification and molecular characterization of diverse cell populations, including myoepithelial cells, fibroblasts, and other epithelial and stromal cell types that undergo age-related changes. The optimized workflow preserves cell integrity and minimizes stress-induced transcriptional artifacts, ensuring accurate representation of in vivo cellular states. Moreover, the methodology is broadly applicable and can be adapted to other exocrine glands or fibrotic tissues, where gentle tissue dissociation and precise isolation of distinct cell populations are critical for downstream single-cell studies.

<table><tbody><tr><td>&lt;strong&gt;Material&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>BSA&amp;nbsp;</td><td>Sigma-Aldrich</td><td>A4919</td><td></td></tr><tr><td>CaCl2 (1&amp;nbsp;M solution)</td><td>BioVision</td><td>B1010-100</td><td></td></tr><tr><td>Collagenase IV</td><td>Sigma-Aldrich</td><td>C5138</td><td></td></tr><tr><td>Dead Cell Removal Kit</td><td>Miltenyi biotec</td><td>130-090-101</td><td></td></tr><tr><td>Dead Cell Removal Kit</td><td>Miltenyi biotec</td><td>130-090-101</td><td></td></tr><tr><td>Dispase II</td><td>Roche</td><td>C756V28</td><td></td></tr><tr><td>DNase I</td><td>Sigma-Aldrich</td><td>DN25-100MG</td><td></td></tr><tr><td>DPBS&amp;nbsp;</td><td>Gibco, Thermo Fisher Scientific</td><td>14190-144</td><td></td></tr><tr><td>Fetal Bovine Serum, ultra-low IgG</td><td>Gibco</td><td># 16250078</td><td></td></tr><tr><td>Hank&#039;s Balanced Salt Solution (HBSS)</td><td>Corning (Thermo Fisher Scientific)</td><td>21-022-CV</td><td></td></tr><tr><td>HEPES (1&amp;nbsp;M solution)</td><td>Sigma-Aldrich</td><td>H0887</td><td></td></tr><tr><td>Isoflurane Solution</td><td>Covertus</td><td># 11695067772</td><td></td></tr><tr><td>MACS&amp;reg; SmartStrainers (30 &amp;micro;m)</td><td>Miltenyi biotec</td><td>130-098-458</td><td></td></tr><tr><td>MACS&amp;reg; SmartStrainers (70 &amp;micro;m)</td><td>Miltenyi biotec</td><td>130-110-916</td><td></td></tr><tr><td>Medium/F12 (DMEM/F12)</td><td>Millipore</td><td>DF-042-B</td><td></td></tr><tr><td>MgCl2 1M</td><td>Sigma-Aldrich</td><td>M1028-100ML</td><td></td></tr><tr><td>MS Columns</td><td>Miltenyi biotec</td><td>130-042-201</td><td></td></tr><tr><td>NaCl (5M stock)</td><td>Invitrogen&amp;trade;</td><td>AM9759</td><td></td></tr><tr><td>Phosphate Buffered Saline (PBS) tablets</td><td>Sigma-Aldrich</td><td>P8920-500ML</td><td></td></tr><tr><td>Red Blood Cell Lysis Solution (10&amp;times;)</td><td>Miltenyi biotec</td><td>130-094-183</td><td></td></tr><tr><td>StemPro Accutase&amp;nbsp;</td><td>Gibco, Thermo Fisher Scientific</td><td>A1110501</td><td></td></tr><tr><td>Trypan Blue Solution, 0.4%</td><td>Gibco, Thermo Fisher Scientific</td><td>15250061</td><td></td></tr><tr><td>Ultra-pure EDTA (0.5M, pH 8.0)</td><td>Invitrogen</td><td>15575020</td><td></td></tr><tr><td>&lt;strong&gt;Antibodies&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>CD140a (PDGFRA) Monoclonal Antibody (APA5), APC-eFluor&amp;trade; 780, Rat / IgG2a, kappa</td><td>eBioscience</td><td>47-1401-82; RRID:AB_2784706</td><td></td></tr><tr><td>FcBlock (CD16/CD32 Fc blocker)</td><td>BD Biosciences&amp;nbsp;</td><td>553141; RRID:AB_394656</td><td></td></tr><tr><td>FxCycle&amp;trade; Violet Stain</td><td>Thermo Fisher Scientific</td><td>F10347</td><td></td></tr><tr><td>Rat CD326 (EpCAM)-APC monoclonal antibody (G8.8), rat IgG2a, kappa</td><td>eBioscience</td><td>17-579182; RRID:AB_2716944</td><td></td></tr><tr><td>&lt;strong&gt;Mice&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>&lt;em&gt;Acta2GFP&amp;nbsp;&lt;/em&gt;</td><td>Kind gift from Dr. Ivo Kalajzic</td><td>PMID: 18571490</td><td></td></tr><tr><td>&lt;em&gt;PdgfraEGFP&amp;nbsp; - B6.129S4-Pdgfratm11(EGFP)Sor/J&lt;/em&gt;</td><td>The Jackson laboratory</td><td>RRID:IMSR_JAX:007669</td><td></td></tr><tr><td>&lt;strong&gt;Equipment&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Invitrogen&amp;trade;&amp;nbsp;Countess&amp;trade; 3 Automated Cell Counter</td><td>Fisher Scientific</td><td>A49862; RRID:SCR_026963</td><td></td></tr></tbody></table>

protocol for single-cell dissociation, rna sequencing, and isolation of myoepithelial cells and fibroblasts from the aged lacrimal and salivary glands

Protocol for Single-Cell Dissociation, RNA Sequencing, and Isolation of Myoepithelial Cells and Fibroblasts from the Aged Lacrimal and Salivary Glands

Aging of the lacrimal gland (LG) is associated with reduced tear secretion and chronic inflammation, contributing to dry eye disease. Age-related LG changes include immune cell infiltration, cellular damage, lipid accumulation in acinar cells, extracellular matrix deposition, and ductal dilation. Single-cell RNA sequencing (scRNA-seq) provides a powerful approach to profile cellular heterogeneity and transcriptional changes during aging; however, generating viable single-cell suspensions from aged LG tissue is technically challenging due to increased fibrosis, cellular fragility, and lipid accumulation. This study presents an optimized, reproducible protocol for the efficient dissociation of aged mouse LGs and the isolation of multiple cell types, suitable for downstream scRNA-seq analysis. Importantly, this protocol is also applicable to young lacrimal glands, conjunctiva, and other exocrine tissues. The workflow employs a stepwise enzymatic dissociation strategy using Collagenase IV, Dispase II, and DNase I for initial tissue digestion, followed by Accutase to dissociate remaining cell clusters and a final DNase I treatment to obtain a clean single-cell suspension. To minimize cell damage, all plasticware is pre-coated with PBS containing bovine serum albumin, and tissue processing is performed under controlled temperature and agitation conditions. Red blood cell lysis and sequential filtration through several strainers further enhance cell purity. Cell type-specific isolation is achieved using reporter mouse lines combined with fluorescence-activated cell sorting (FACS). Using Acta2GFP and PdgfraEGFP&#160;mice, we successfully isolated myoepithelial cells and fibroblasts, respectively, following immunostaining with an EpCAM antibody. FACS enabled the separation of the EpCAM&#8314;/&#945;SMA&#8314; myoepithelial population, while EGFP&#8314;&#160;cells from PdgfraEGFPmice represented the fibroblast population. This protocol yields high-quality, viable single-cell suspensions from aged LGs and can be readily adapted to other fibrotic or aging exocrine tissues requiring gentle dissociation and targeted cell isolation.

Dissociating aged exocrine glands is challenging due to lipid accumulation and extensive ECM deposition. Aged glands exhibit marked lymphocytic infiltration and pronounced ductal dilation with intraluminal material, reflecting the structural and inflammatory changes that complicate tissue dissociation. The lacrimal gland is an exocrine organ composed of three principal epithelial cell types: acinar, ductal, and myoepithelial cells. Acinar cells produce the aqueous and protein components of the tear film that maintain cor...

This protocol describes an optimized method for dissociating aged mouse lacrimal glands to obtain viable single cells for single-cell RNA sequencing. Sequential enzymatic digestion and gentle handling preserve cell integrity, yielding high-quality suspensions suitable for cell-type-specific isolation and transcriptomic analysis of aging-associated changes in lacrimal gland populations.

Aging of the lacrimal gland (LG) is associated with reduced tear secretion and chronic inflammation, contributing to dry eye disease. Age-related LG ...

My lab studies how age-related changes in salivary and lacrimal glands affect different cell types using flow cytometry and single-cell RNA sequencing. Standard dissociation methods poorly recover fragile epithelial cells from aged salivary and lacrimal glands. And my protocol improves cell viability and enable reliable single-cell analysis and cell sorting.To begin, position the euthanized mouse supine on the dissection table. Using fine forceps and scissors, incise the skin between the eye and the ear. Gently retract the skin to expose the lacrimal gland.Using dull-tipped forceps, lift the lacrimal gland slightly. Carefully separate the surrounding connective tissue by gently teasing it away in a circular motion. Identify the visible boundaries of the lacrimal gland and separate it from adjacent tissues, including the parotid gland.Then transfer the lacrimal gland to a 35-millimeter Petri dish containing two milliliters of cold PBS on ice. Under a dissecting microscope, remove the remaining fat, and carefully remove the connective tissue capsule from the lacrimal gland. Place a sterile 35-millimeter Petri dish on ice.Add 800 to 1000 microliters of cold PBS to the center of the dish and transfer one lacrimal gland into the PBS. Ensure the tissue remains submerged in PBS. Using two sterile scalpels, finely mince the lacrimal gland into small fragments until it reaches a soft paste-like consistency.Collect the tissue fragments to one side of the dish. Aspirate the residual PBS and wash the fragments with one milliliter of fresh cold PBS. Transfer the washed tissue fragments into a 12-well plate containing two milliliters per well of pre-warmed digestion medium.Place the plate in a shaking water bath and incubate at 37 degrees Celsius and 60 revolutions per minute for 30 minutes. Using a wide-bore one-milliliter pipette tip, gently triturate the tissue 15 times. Return the plate to the shaking water bath and incubate for an additional 30 minutes.Next, using a regular one-milliliter pipette tip, gently triturate the sample 10 times and incubate again for 30 minutes. Then gently triturate the sample 10 times and transfer the cell suspension into two-milliliter dolphin micro centrifuge tubes. Add one milliliter of cold blocking medium one, or BM1, to each well of the plate to collect the remaining digestion medium containing residual cells and place the plate on ice until the next step.Centrifuge the tubes containing the cell suspension at 300 G for five minutes at four degrees Celsius. Discard the supernatant from each tube. Transfer the BM1 from each well of the plate containing residual cells into the corresponding tube.Next, add 600 microliters of cold BM1 to each well to rinse the remaining cells and transfer the wash into the corresponding tube to combine with the cell suspension. Gently resuspend the cell suspension. Centrifuge the tubes again at 300 G for five minutes at four degrees Celsius and discard the supernatant.Add one milliliter of Accutase to the cell pellets and gently resuspend the cells. Incubate the tube at 37 degrees Celsius and 60 revolutions per minute for five to 10 minutes. Using a one-milliliter pipette tip, gently triturate the sample 10 times.Then add one milliliter of cold BM2 to the tube to terminate the enzymatic reaction by diluting the Accutase. Centrifuge the tube at 300 G for five minutes at four degrees Celsius and discard the supernatant. Add medium containing DNase 1 at a concentration of 200 units per milliliter to the tube to resuspend the cells and fill the tube to the top.Incubate the tube for 10 minutes at room temperature, and gently resuspend once after five minutes. Meanwhile, place a 70-micrometer cell strainer over a 15-milliliter conical tube, and pre-wet the strainer with one milliliter of BM3. After incubation, transfer the cell suspension onto the strainer.Add one milliliter of BM3 into the original collection tube to rinse it and transfer the rinse onto the same strainer. Wash the strainer with an additional five milliliters of BM3. Finally, determine cell concentration and viability of the filtered cell suspension using trypan blue stain and an automated cell counter.Proceed with downstream applications, such as single-cell RNA sequencing for gene expression profiling, or flow cytometry-based cell sorting of fluorescently-labeled cell populations. UMAP analysis of single-cell RNA sequencing data identified well-represented epithelial and stromal populations in the lacrimal gland, including myoepithelial cells and fibroblasts, as well as diverse immune cell populations. Aged lacrimal glands contained abundant plasma and activated B cells expressing IGHM and IGHD.Sequential flow cytometry gating enabled clear separation of EpCAM-positive, GFP-positive myoepithelial cells from EpCAM-negative, GFP-positive mural cells. GFP-positive fibroblasts expressing PDGFR alpha were EpCAM-negative, allowing discrimination from epithelial cells. In PDGFR alpha, EGFP mice, all GFP-positive cells also expressed collagen one, confirming fibroblast identity.Flow cytometry analysis showed that 99.6%of GFP-positive cells corresponded to PDGFR alpha immunostained cells. This protocol is designed to isolate viable single cells from lacrimal glands for molecular characterization of epithelial, stromal, and immune populations. The main challenge is minimizing mechanical and enzymatic stress during disassociation of fragile aged tissue, while also maintaining high cell viability for single-cell RNA sequencing.Following this procedure, isolated cells can be used for single-cell RNA sequencing, bulk RNA sequencing, and molecular profiling of specific cell populations. Sorted cells can also be cultured for downstream functional assays.

protocol-for-single-cell-dissociation-rna-sequencing-isolation

Research

JoVE Journal

Biology

Organ specific sensory neurons are difficult to identify. Fast Blue tracing is used to identify nodose neurons innervating the airways for cell sorting. Sorted nodose neurons are used to extract high quality ribonucleic acid (RNA) for sequencing. Using this protocol, gene expression of airway specific neurons is determined.

A Method to Target and Isolate Airway-innervating Sensory Neurons in Mice

The goal of this protocol is to obtain high-integrity RNA samples from enteric ganglia isolated from unfixed, freshly-resected human intestinal tissue using laser capture microdissection (LCM). This protocol involves preparing flash-frozen samples of human intestinal tissue, cryosectioning, ethanolic staining and dehydration, LCM, and RNA extraction.

Optimization of Laser-Capture Microdissection for the Isolation of Enteric Ganglia from Fresh-Frozen Human Tissue

The lacrimal gland (LG) has two cell types expressing α-smooth muscle actin (αSMA): myoepithelial cells (MECs) and pericytes. MECs are of ectodermal origin, found in many glandular tissues, while pericytes are vascular smooth muscle cells of endodermal origin. This protocol isolates MECs and pericytes from murine LGs.

Isolation of Myoepithelial Cells from Adult Murine Lacrimal and Submandibular Glands

We present a method for isolating and cultivating primary human salivary gland-derived epithelial cells. These cells exhibit gene expression patterns consistent with them being of salivary epithelial origin and can be grown as salispheres on basement membrane matrices derived from Engelbreth-Holm-Swarm tumor cells or as monolayers on treated culture dishes.

Isolation of Salivary Epithelial Cells from Human Salivary Glands for In Vitro Growth as Salispheres or Monolayers

This protocol describes laser capture microdissection for the isolation of cartilage and bone from fresh frozen sections of the mouse embryo. Cartilage and bone can be rapidly visualized by cresyl violet staining and collected precisely to yield high quality RNA for transcriptomic analysis.

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis

Obtaining a pure population of fibroblasts is crucial to studying their role in wound repair and fibrosis. Described here is a detailed method to isolate fibroblasts and myofibroblasts from uninjured and injured mouse hearts followed by characterization of their purity and functionality by immunofluorescence, RTPCR, fluorescence-assisted cell sorting, and collagen gel contraction.

Isolation and Characterization of Adult Cardiac Fibroblasts and Myofibroblasts

The current protocol presents a fast, efficient, and gentle method for isolating single cells suitable for single-cell RNA-seq analysis from a continuously growing mouse incisor, mouse molar, and human teeth.

Rapid Isolation of Single Cells from Mouse and Human Teeth

A method for microdissection of the mouse oviduct that allows collection of the individual segments while maintaining RNA integrity is presented. In addition,  non-enzymatic oviductal cell dissociation procedure is described. The methods are appropriate for subsequent gene and protein analysis of the functionally different oviductal segments and dissociated oviductal cells.

Microdissection and Dissociation of the Murine Oviduct: Individual Segment Identification and Single Cell Isolation

This article provides a streamlined protocol for the dissection and dissociation of murine olfactory epithelium for the purpose of single-nucleus RNA sequencing.

Rapid Dissection and Dissociation of the Mouse Olfactory Epithelium for Single-Nucleus Suspensions

This protocol details the separation of the mouse ocular lens epithelium and fiber cell bulk mass, followed by RNA isolation and qPCR analysis. This method allows for separating lens cell compartments for a more detailed analysis of the transcriptome and biological processes in epithelial cells vs. differentiated fiber cells.

RNA Isolation from Mouse Ocular Lens Epithelium and Fiber Cell Bulk Masses

Learn single-cell dissociation and RNA sequencing for aged lacrimal glands using optimized enzymatic digestion and FACS. This protocol enables high-quality isolation of myoepithelial cells and fibroblasts.

Protocol for Single-Cell Dissociation, RNA Sequencing, and Isolation of Myoepithelial Cells and Fibroblasts from the Aged Lacrimal and Salivary Glands (Video) | JoVE Journal

Protocol for Single-Cell Dissociation, RNA Sequencing, and Isolation of Myoepithelial Cells and Fibroblasts from the Aged Lacrimal and Salivary Glands

Explore More Videos